Please Wait a Moment
X

Articles

05Feb

MD Revised Headers on CTS forms

05 Feb, 2018 | Return|

Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications

Related

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

Discontinue HIV-1 IFA Confirmatory Test

CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...

Read More >

Reminder- The CTS Reentry form- CTS-00172 implements 7/2/18

Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...

Read More >

CTS moving to new sFTP Server

CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...

Read More >